Abstract
Chagas disease (ChD) is one of the most neglected tropical diseases, with cardiomyopathy being the main cause of death in Trypanosoma cruzi-infected patients. As the parasite actively replicates in cardiomyocytes (CMs), the heart remains a key target organ in the pathogenesis of ChD. Here we modeled ChD using human induced pluripotent stem cell-derived CMs (iPSC-CMs) to understand the complex interplay between the parasite and host cells. We showed that iPSC-CMs can get infected with the T. cruzi Y strain and that all parasite cycle stages can be identified in our model system. Importantly, characterization of T. cruzi-infected iPSC-CMs showed significant changes in their gene expression profile, cell contractility, and distribution of key cardiac markers. Moreover, these infected iPSC-CMs exhibited a pro-inflammatory profile as indicated by significantly elevated cytokine levels and cell-trafficking regulators. We believe our iPSC-CM model is a valuable platform to explore new treatment strategies for ChD.
| Original language | Undefined/Unknown |
|---|---|
| Pages (from-to) | 1232-1241 |
| Number of pages | 10 |
| Journal | Stem Cell Reports |
| Volume | 12 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - 16 May 2019 |
Keywords
- cardiomyopathy
- Chagas disease
- disease modeling
- drug screening
- induced pluripotent stem cells
- Trypanosoma cruzi